Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Ectodysplasin-A1 is crucial for developing hair, teeth, and glands.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

SLE patients with Evans syndrome often show blood issues and need careful monitoring and treatment.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

The 2012 criteria are better for diagnosing atypical lupus cases.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Early treatment with corticosteroids and immunosuppressants is crucial for managing Vogt-Koyanagi-Harada disease.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Genomic profiling for myeloid cancers can find important inherited mutations, but it's challenging when these mutations aren't related to the patient's symptoms.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Sensitive scalp causes discomfort and hair loss, treated with personalized care.

Hair loss in a child was an early sign of Crohn's disease.

Excimer laser therapy may help improve scarring alopecia symptoms and hair appearance.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

Chlorine gas exposure can cause long-term skin issues.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

Cyclosporine is more effective than betamethasone for treating alopecia areata, despite mild side effects.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

Trichoscopy is a quick, accurate, and non-invasive method to diagnose and treat non-scarring hair loss.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.